FIRST OPEN-HEART SURGERY PERFORMED IN THE MDMG LAPINO HOSPITAL
|Download file (109 K)|
28 June 2021, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, today announces that for the first time in the practice of the Lapino clinical hospital a coronary artery bypass shunting was performed on a patient with massive coronary artery damage. This operation was performed on an open heart using a heart-lung machine (AIC). At the moment, the patient feels well and was released for outpatient therapy.
Treatment of patients with cardiovascular diseases in the Lapino hospital began in 2016. Medical care was provided to patients with cardio ischemia, vascular diseases and some forms of congenital heart disease. Later on, the range of services in this area expanded. We began to treat patients with various types of cardiac rhythm disorder, implant pacemakers and cardioverter-defibrillators and perform radiofrequency and cryoablation. In the course of five years more than 1,500 patients received medical help.
Now the Lapino hospital has the opportunity to provide a full cycle of cardiac and cardiac surgery care to patients with pathologies of the cardiovascular system. In addition to endovascular surgery, it will be possible to perform operations on patients with severe dysfunctions of coronary arteries or pathology of the heart valves that require an open heart surgery with sternotomy.
The launch of the cardiovascular surgery department at the Lapino hospital and the start of operations under cardiopulmonary bypass will make possible hybrid surgery during which endovascular surgeons will perform endovascular implantation of heart valves, engage in endoprosthetics of the abdominal aortic aneurysm with the support of cardiac surgeons.
Mark Kurtser, CEO of MD Medical Group, said:
“6 years ago we opened a department of X-ray surgical methods of cardiodiagnosis and cardiotreatment in our hospital in Lapino. It gave an impulse to the development of all cardiac surgery within the Group. The successful operation on a beating heart opens a new page in the work of our hospital and strengthens the multidisciplinary status of the medical complex in Lapino”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 (495) 139-87-40, ext. 16329
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok, Krasnodar and Rostov-on-Don.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Since November 9, 2020 the Company's GDRs are traded also on the Moscow Exchange. Quotation is done in Russian Rubles.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2021 2020 2019 2018 2017 2016 2015 2014 2013 2012